BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghosh S, Marrocco I, Yarden Y. Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment. Adv Cancer Res 2020;147:1-57. [PMID: 32593398 DOI: 10.1016/bs.acr.2020.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ledoux J, Trouvé A, Tchertanov L. Folding and Intrinsic Disorder of the Receptor Tyrosine Kinase KIT Insert Domain Seen by Conventional Molecular Dynamics Simulations. Int J Mol Sci 2021;22:7375. [PMID: 34298994 DOI: 10.3390/ijms22147375] [Reference Citation Analysis]
2 Dos Santos HT, Kim K, Okano T, Camden JM, Weisman GA, Baker OJ, Nam K. Cell Sheets Restore Secretory Function in Wounded Mouse Submandibular Glands. Cells 2020;9:E2645. [PMID: 33316992 DOI: 10.3390/cells9122645] [Reference Citation Analysis]
3 Lawal B, Lee CY, Mokgautsi N, Sumitra MR, Khedkar H, Wu ATH, Huang HS. mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications. Front Oncol 2021;11:656738. [PMID: 33842373 DOI: 10.3389/fonc.2021.656738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
4 Chen L, Kong X, Fang Y, Paunikar S, Wang X, Brown JAL, Bourke E, Li X, Wang J. Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer. Front Cell Dev Biol 2021;9:747314. [PMID: 34805157 DOI: 10.3389/fcell.2021.747314] [Reference Citation Analysis]
5 Zengin M, Unsal Tan O, Arafa RK, Balkan A. Design and Synthesis of New 2-Oxoquinoxalinyl-1,2,4-triazoles as Antitumor VEGFR-2 Inhibitors. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105696] [Reference Citation Analysis]
6 Chen P, Zhao Y, Zhang J, Duan Y, Dai J, He J, Wang X, Chen X, Chen P, Zhao W, Wang X, Zhuang Z, Yang D, Liang G, Tang Q. Design, synthesis and anticancer evaluation of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 1,8-naphthyridine-3-carboxamide moiety as novel multi-target TKIs. Bioorg Chem 2022;121:105672. [PMID: 35202851 DOI: 10.1016/j.bioorg.2022.105672] [Reference Citation Analysis]
7 Amer M, Shi L, Wolfenson H. The 'Yin and Yang' of Cancer Cell Growth and Mechanosensing. Cancers (Basel) 2021;13:4754. [PMID: 34638240 DOI: 10.3390/cancers13194754] [Reference Citation Analysis]
8 Sigismund S, Lanzetti L, Scita G, Di Fiore PP. Endocytosis in the context-dependent regulation of individual and collective cell properties. Nat Rev Mol Cell Biol 2021;22:625-43. [PMID: 34075221 DOI: 10.1038/s41580-021-00375-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Shao WQ, Zhu WW, Luo MJ, Fan MH, Li Q, Wang SH, Lin ZF, Zhao J, Zheng Y, Dong QZ, Lu L, Jia HL, Zhang JB, Lu M, Chen JH, Qin LX. Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma. Cell Rep 2022;39:110712. [PMID: 35443161 DOI: 10.1016/j.celrep.2022.110712] [Reference Citation Analysis]
10 Kumar R, Paul AM, Amjesh R, George B, Pillai MR. Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases. Cancer Metastasis Rev 2020;39:583-601. [PMID: 32820388 DOI: 10.1007/s10555-020-09922-6] [Reference Citation Analysis]